Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease
Abstract Revascularization surgery is considered a standard treatment for preventing additional stroke in symptomatic moyamoya disease (MMD). In hemodynamically stable, and asymptomatic or mildly symptomatic patients, however, the treatment strategy is controversial because of the obscure natural co...
Guardado en:
Autores principales: | Chang Hwan Pang, Won-Sang Cho, Hyun-Seung Kang, Jeong Eun Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fd256a1518764bd19fecd83a1e8300f6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Difference in Cerebral Circulation Time between Subtypes of Moyamoya Disease and Moyamoya Syndrome
por: Kaijiang Kang, et al.
Publicado: (2017) -
Long-term cognitive changes after revascularization surgery in adult patients with ischemic moyamoya disease
por: Shun Uchida, et al.
Publicado: (2021) -
Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease
por: Brandon M. Fox, et al.
Publicado: (2021) -
Serum miRNA signature in Moyamoya disease.
por: Dongwei Dai, et al.
Publicado: (2014) -
Different levels of blood pressure, different benefit from dual antiplatelet therapy in minor stroke or TIA patients
por: Jie Xu, et al.
Publicado: (2017)